Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma
暂无分享,去创建一个
Wei Li | Jun Zhu | X. Ke | Jifeng Feng | Hui-Qiang Huang | Ye Guo | Wei Xu | Yi Dai | Yuqin Song | J. Kinley | G. Song | H. Miao | Hui Wang | Huiqiang Huang